Urokinase receptor is a key player in tumour progression
暂无分享,去创建一个
[1] N. Lemoine,et al. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer. , 1998, Cancer research.
[2] S. L. Gonias,et al. Binding of Urokinase-type Plasminogen Activator to Its Receptor in MCF-7 Cells Activates Extracellular Signal-regulated Kinase 1 and 2 Which Is Required for Increased Cellular Motility* , 1998, The Journal of Biological Chemistry.
[3] O. Mayboroda,et al. The Jak/Stat Pathway and Urokinase Receptor Signaling in Human Aortic Vascular Smooth Muscle Cells* , 1998, The Journal of Biological Chemistry.
[4] M. Shuman,et al. Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade. , 1997, Cancer research.
[5] Y. Wei,et al. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. , 1997, The Journal of clinical investigation.
[6] Y. Kook,et al. Co‐expression of urokinase‐type plasminogen activator and its receptor in human gastric‐cancer cell lines correlates with their invasiveness and tumorigenicity , 1997, International journal of cancer.
[7] E. Lengyel,et al. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade , 1997, Oncogene.
[8] L. Ossowski,et al. Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy , 1997, The Journal of cell biology.
[9] J. Foidart,et al. Involvement of PA/plasmin system in the processing of pro‐MMP‐9 and in the second step of pro‐MMP‐2 activation , 1997, FEBS letters.
[10] H. Sato,et al. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin , 1997, FEBS letters.
[11] H. Friess,et al. Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma. , 1997, British Journal of Cancer.
[12] Michael V. Doyle,et al. Regulation of Integrin Function by the Urokinase Receptor , 1996, Science.
[13] F. Blasi,et al. Proteolytic cleavage of the urokinase receptor substitutes for the agonist‐induced chemotactic effect. , 1996, The EMBO journal.
[14] J. Otte,et al. Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. , 1995, Nucleic acids research.
[15] J. Skibber,et al. Transcriptional activation of the urokinase receptor gene in invasive colon cancer , 1994, International journal of cancer.
[16] H. Verspaget,et al. Urokinase receptor and colorectal cancer survival , 1994, The Lancet.
[17] S. Waxman,et al. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells , 1994, The Journal of cell biology.